Improving compliance and assurance for the Prescribed List

Learn about compliance and assurance measures to safeguard the settings of the Prescribed List.

What the reform is about

We are setting up a compliance and assurance function to maintain the integrity of the Prescribed List and provide assurance that policy outcomes are being met.

How we will achieve this

Our first step was to develop the Prescribed List Compliance Strategy. The strategy:

  • outlines the principles which govern our compliance and enforcement functions and priorities
  • describes suspected and actual non-compliance
  • sets out the steps we may take if there are concerns about non-compliant activities or behaviours
  • will apply to all Prescribed List stakeholders, such as health professionals, private hospitals, private health insurers, clinicians, sponsors and manufacturers
  • takes into account suggestions from stakeholders.

Timeline

We undertook consultation on proposed compliance, assurance and information sharing measures. We have released the stakeholder feedback analysis reports:

Past activities

DateActivity
23 May to 13 June 2024

Further consultation on two compliance measures: 
1) Gifts, benefits and discounts reporting requirements

2) Alignment of amount charged for supply of a device with corresponding PL benefit

12 July to 10 August 2023Consultation on the proposed measures for compliance assurance and information sharing
18 May 2023Released the Prescribed List Compliance Strategy and stakeholder feedback report
September to October 2022Consultation on the draft Prescribed List Compliance Strategy
Date last updated:

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.